Patients on high doses of a popular weight-loss drug shed fewer pounds than those on a lower dose, a study has found.

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

The side effects of eating more than the small amount would lead him to become so bloated that he would burp twice every three minutes for hours, and they would smell like sulphur.

EXPERTS have revealed there could be a ‘golden dose’ of Mounjaro that helps shift the most weight – and it’s not the highest ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

The booming uptake of anti-obesity drugs in India is further underscored by rising momentum of Eli Lilly's Mounjaro, which ...

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Ram Kapoor defended the use of Ozempic for weight loss, emphasising that it requires a doctor's prescription. He criticised societal negativity around its use.

A handful of New York City-based restaurants are handing out ‘Ozempic portions’ to diners, as over 7.2 million Americans are using the weight-loss drug or similar in 2025 according to Yale University.

Patients taking GLP-1 weight loss drugs are reporting a potentially new fatal side effect when taking Ozempic and Mounjaro: acute pancreatitis.